论文信息 - Converting non-neutralizing SARS-CoV-2 antibodies into broad-spectrum inhibitors - 字舞流文

Converting non-neutralizing SARS-CoV-2 antibodies into broad-spectrum inhibitors

E. Waltari | M. Morris | Peter S. Kim | J. Pak | Benjamin N. Bell | C. Hanson | P. Weidenbacher | Izumi de los Rios Kobara | Ya-Chen Cheng | Eric Waltari